by Giridharan Ramsingh, Meagan A. Jacoby, Jin Shao, Rigoberto E

Slides:



Advertisements
Similar presentations
The angiogenesis inhibitor vasostatin is regulated by neutrophil elastase–dependent cleavage of calreticulin in AML patients by Sarah Mans, Yara Banz,
Advertisements

Stem cell concepts renew cancer research by John E. Dick Blood Volume 112(13): December 15, 2008 ©2008 by American Society of Hematology.
Date of download: 6/22/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Identification of a Novel TP53 Cancer Susceptibility.
Homozygous deletions within chromosome 9q23.
Fig. 1. Genomic analysis. (A) Array CGH analysis of chromosome 12 performed on DNA from blood lymphocytes. Log 2 ratio data are presented according to.
BCR-ABL nuclear entrapment kills human CML cells: ex vivo study on 35 patients with the combination of imatinib mesylate and leptomycin B by Alessandra.
Hypoxia increases IL-32 expression in an HIF1α-dependent manner.
by Adrianna Vlachos, Jason E
EHT, a New Member of the MTG8/ETO Gene Family, Maps on 20q11 Region and Is Deleted in Acute Myeloid Leukemias by Nicola Stefano Fracchiolla, Gualtiero.
Evidence for the involvement of a hematopoietic progenitor cell in systemic mastocytosis from single-cell analysis of mutations in the c-kit gene by A.
Fig. 1. TP is highly expressed in myeloma.
A Strategy to Find Suitable Reference Genes for miRNA Quantitative PCR Analysis and Its Application to Cervical Specimens  Iris Babion, Barbara C. Snoek,
by Leah J. Anderson, and Richard Longnecker
by Nancy D. Borson, Martha Q. Lacy, and Peter J. Wettstein
Mild preconditioning and low-level engraftment confer methotrexate resistance in mice transplanted with marrow expressing drug-resistant dihydrofolate.
Clonal origins of relapse in ETV6-RUNX1 acute lymphoblastic leukemia
The MLL partial tandem duplication: evidence for recessive gain-of-function in acute myeloid leukemia identifies a novel patient subgroup for molecular-targeted.
Arginine deprivation using pegylated arginine deiminase has activity against primary acute myeloid leukemia cells in vivo by Farideh Miraki-Moud, Essam.
Telomerase and telomere length in multiple myeloma: correlations with disease heterogeneity, cytogenetic status, and overall survival by Kai-Da Wu, Lisa.
by Venetia Bigley, Laura E. Spence, and Matthew Collin
by Jaroslaw P. Maciejewski, and Ghulam J. Mufti
Somatic mutations and germline sequence variants in the expressed tyrosine kinase genes of patients with de novo acute myeloid leukemia by Michael H. Tomasson,
by Susan E. Shetzline, Ravikumar Rallapalli, Kelley J
Hypomethylation Status of CpG Sites at the Promoter Region and Overexpression of the Human MDR1 Gene in Acute Myeloid Leukemias by Masaharu Nakayama, Morimasa.
Gupta V, Tallman MS, Weisdorf DJ
Novel chromosomal imbalances in mantle cell lymphoma detected by genome-wide array-based comparative genomic hybridization by Margit Schraders, Rolph Pfundt,
The C/EBPδ tumor suppressor is silenced by hypermethylation in acute myeloid leukemia by Shuchi Agrawal, Wolf-Karsten Hofmann, Nicola Tidow, Mathias Ehrich,
Acute myeloid leukemia creates an arginase-dependent immunosuppressive microenvironment by Francis Mussai, Carmela De Santo, Issa Abu-Dayyeh, Sarah Booth,
Progressive Telomere Shortening in Aplastic Anemia
by Martin de Boer, Egbert Bakker, Stefaan Van Lierde, and Dirk Roos
Aurora kinase inhibitory VX-680 increases Bax/Bcl-2 ratio and induces apoptosis in Aurora-A-high acute myeloid leukemia by Xue-Fei Huang, Shao-Kai Luo,
Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with.
Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia by Teresa Padró, Sandra Ruiz, Ralf Bieker, Horst Bürger, Martin Steins,
A leukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemia by Gerald G. Wulf, Rui-Yu Wang, Ingrid Kuehnle, Douglas Weidner, Frank.
Circulating blood dendritic cells from myeloid leukemia patients display quantitative and cytogenetic abnormalities as well as functional impairment by.
Detection of Trisomy 12 and Rb-Deletion in CD34+ Cells of Patients With B-Cell Chronic Lymphocytic Leukemia by B. Gahn, C. Schäfer, J. Neef, C. Troff,
Relative increase in leukemia-specific DNA in peripheral blood plasma from patients with acute myeloid leukemia and myelodysplasia by Anna Rogers, Youngson.
by Thomas A. Paul, Juraj Bies, Donald Small, and Linda Wolff
by David M. Weinstock, Beth Elliott, and Maria Jasin
by Douglas D. Ross, Judith E. Karp, Tar T. Chen, and L. Austin Doyle
Primitive quiescent leukemic cells from patients with chronic myeloid leukemia spontaneously initiate factor-independent growth in vitro in association.
Expression profiling of snoRNAs in normal hematopoiesis and AML
Therapeutic levels of fetal hemoglobin in erythroid progeny of β-thalassemic CD34+ cells after lentiviral vector-mediated gene transfer by Andrew Wilber,
Enrichment of functional CD8 memory T cells specific for MUC1 in bone marrow of patients with multiple myeloma by Carmen Choi, Mathias Witzens, Marianna.
Alterations of the Cell-Cycle Inhibitors p27KIP1 and p16INK4a Are Frequent in Blastic Plasmacytoid Dendritic Cell Neoplasms  Thomas Wiesner, Anna C. Obenauf,
Genome-wide Profiling in AML Patients Relapsing after Allogeneic Hematopoietic Cell Transplantation  Miguel Waterhouse, Dietmar Pfeifer, Milena Pantic,
LEF-1 is a prosurvival factor in chronic lymphocytic leukemia and is expressed in the preleukemic state of monoclonal B-cell lymphocytosis by Albert Gutierrez,
Yang et al. SALL4 is a key regulator of survival and apoptosis in human leukemic cells. Blood. 2008;112(3):805–813. Blood Volume 114(14): October.
Qing Cheng, Cheng Cheng, Kristine R. Crews, Raul C
Cytokine-Release Syndrome in Patients With B-Cell Chronic Lymphocytic Leukemia and High Lymphocyte Counts After Treatment With an Anti-CD20 Monoclonal.
Microarray Techniques to Analyze Copy-Number Alterations in Genomic DNA: Array Comparative Genomic Hybridization and Single-Nucleotide Polymorphism Array 
Loss of imprinting at the 14q32 domain is associated with microRNA overexpression in acute promyelocytic leukemia by Floriana Manodoro, Jacek Marzec, Tracy.
Kelsie L. Thu, BSc, Raj Chari, PhD, William W
Gerald B. W. Wertheim, Catherine Smith, Maria E
Emerging Importance of Mutational Analysis in Myelodysplastic Syndrome and Acute Myelogenous Leukemia  Aaron T. Gerds, Matthew J. Walter, Bart L. Scott 
A, genomic copy number profiles of chromosome 8 with array CGH in SUM-44, -52, and A, genomic copy number profiles of chromosome 8 with array CGH.
Volume 23, Issue 1, Pages (January 2015)
BCR-ABL1 gene rearrangement as a subclonal change in ETV6-RUNX1–positive B-cell acute lymphoblastic leukemia by Karen A. Dun, Rob Vanhaeften, Tracey J.
Impact of RTEL1 variants on telomere maintenance.
Decreased expression of cell cycle– and apoptosis-related genes in Aml1-excised leukemia cell. Decreased expression of cell cycle– and apoptosis-related.
Whole-chromosome view of gene density, inverse environmental variation, inverse total variation, and open chromatin signature. Whole-chromosome view of.
Expression analysis of the C-MYB gene in T-ALL.
Survival based on V gene mutation status and CD38 expression among B-CLL patients who stratify to the Rai intermediate risk category. Survival based on.
Leukemic blasts express a “hypoxia signature
Cell lines with aberrant expression of NRG1 are exquisitely sensitive to downregulation of ERBB3 signaling. Cell lines with aberrant expression of NRG1.
A, heatmap of copy number alterations determined by array CGH for a panel of 79 frozen NSCLC samples. A, heatmap of copy number alterations determined.
Qing Cheng, Cheng Cheng, Kristine R. Crews, Raul C
How I treat T-cell acute lymphoblastic leukemia in adults
Integrated analysis of gene expression and copy number alterations.
Genomic and proteomic profiling of ovarian cancer cell lines.
Presentation transcript:

Acquired copy number alterations of miRNA genes in acute myeloid leukemia are uncommon by Giridharan Ramsingh, Meagan A. Jacoby, Jin Shao, Rigoberto E. De Jesus Pizzaro, Dong Shen, Maria Trissal, Angela H. Getz, Timothy J. Ley, Matthew J. Walter, and Daniel C. Link Blood Volume 122(15):e44-e51 October 10, 2013 ©2013 by American Society of Hematology

Hemizygous loss of MIR-223 in a patient with AML Hemizygous loss of MIR-223 in a patient with AML. (A) Log2 ratio dot plots of paired tumor and normal DNA from patient UPN 864484 analyzed by using the custom CGH array. Hemizygous loss of MIR-223 in a patient with AML. (A) Log2 ratio dot plots of paired tumor and normal DNA from patient UPN 864484 analyzed by using the custom CGH array. A discrete deletion of approximately 429 kb on chromosome X is depicted. Genomic coordinates are based on NCIBI36/HG18 assembly. (B) Quantitative PCR for MIR223 and MIR181b (control gene) was performed by using genomic DNA from the indicated source. Shown is the ratio of MIR223 to MIR181b signal. Data represent the mean ± standard error of the mean of triplicate measurements. (C) miR-223 expression relative to RNU48 is shown for CD34+ cells isolated from healthy donors (CD34) and leukemic bone marrow from patient UPN 864484 or 28 other patients with AML. The 90% confidence interval is shown for CD34+ cells. Giridharan Ramsingh et al. Blood 2013;122:e44-e51 ©2013 by American Society of Hematology